Remove 2013 Remove Nuclear Medicine Remove Radiation
article thumbnail

Treatment paradigm shifting for men with prostate cancer

AuntMinnie

New imaging and treatment strategies are emerging to prolong the lives of men with metastatic castration-resistant prostate cancer (mCRPC), according to a presentation at the recent Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. Expanding field Ultimately, the field is ever-expanding, Zukotynski said.

article thumbnail

Sgouros honored with SNMMI's Paul C. Aebersold award

AuntMinnie

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has bestowed its Paul C. Aebersold Award for outstanding achievement in basic nuclear medicine science on George Sgouros, PhD, of Johns Hopkins Medicine in Baltimore. George Sgouros, PhD, of Johns Hopkins Medicine in Baltimore.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AuntMinnie 2011: Joint Commission issues alert on medical radiation

AuntMinnie

Joint Commission on the dangers of medical radiation. Joint Commission has issued an alert on the dangers of medical radiation, sending an unmistakable signal that radiology has entered its sights in a formal way. California will implement even stricter requirements beginning in January 2013. Noting that the U.S.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval. It's full-spectrum, personalized care," Vroman told AuntMinnie.com.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval. It's full-spectrum, personalized care," Vroman told AuntMinnie.com.

article thumbnail

Percutaneous Cholecystostomy in Pregnancy

Global Radiology CME

The patient is pregnant (orange arrows), therefore ionizing radiation with CT scan or fluoroscopy can not be used for imaging guidance. A nuclear medicine hepatobiliary scan was also performed (not shown) and demonstrated no radiopharmaceutical present in the gallbladder due to cystic duct obstruction. 2013;(8): CD007088.